PhoreMost in drug target discovery collaboration with Roche

PhoreMost – the UK-based biopharmaceutical company dedicated to ‘drugging the undruggable’ – has announced a multi-project target discovery collaboration with Roche. Under the terms of the agreement, PhoreMost will receive an upfront payment and is also eligible for preclinical success-based milestones.